Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Paving the way for renewed antibacterial R&D

    • 12 Accesses

    This is a preview of subscription content, log in to check access.


    1. 1.

      Fox JL.The business of developing antibacterials. Nature Biotechnology 24: 1521-1528, No. 12, Dec 2006

    2. 2.

      Katz ML, Mueller LV, Polyakov M, Weinstock SF.Where have all the antibiotic patents gone? Nature Biotechnology 24: 1529-1531, No. 12, Dec 2006

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Paving the way for renewed antibacterial R&D. Pharmacoecon. Outcomes News 522, 3 (2007). https://doi.org/10.2165/00151234-200705220-00006

    Download citation


    • Public Health
    • Infectious Disease
    • Health Outcome
    • Health Economic
    • Review Process